MedTrace Logo

Histologic Comparison of Ablative Techniques for Endometriosis

NCT06414083 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 141

Last updated 2024-05-30

No results posted yet for this study

Summary

To our knowledge, no other human studies directly compare the effectiveness of the various ablative technologies. We set out to design a study to directly compare ablative energy sources and evaluate their ability to destroy native endometriosis tissue in humans.

Conditions

  • Endometriosis
  • Endometriosis-related Pain
  • Endometriosis Pelvic
  • Endometriosis; Peritoneum

Interventions

DEVICE

Diathermy

Diathermy will be used to ablate the randomized sample.

DEVICE

CO2 Laser

CO2 Laser will be used to ablate the randomized sample.

DEVICE

Argon Beam Coagulator

Argon Beam Coagulator will be used to ablate the randomized sample.

Sponsors & Collaborators

  • TriHealth Inc.

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-09
Primary Completion
2025-05-09
Completion
2025-06-09
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06414083 on ClinicalTrials.gov